Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1)

Cancer
Jonathan D SchwartzYan Wu

Abstract

The human vascular endothelial growth factor receptor-1 (VEGFR-1, or Flt-1) is widely expressed in normal and pathologic tissue and contributes to the pathogenesis of both neoplastic and inflammatory diseases. In human cancer, VEGFR-1 mediated signaling is responsible for both direct tumor activation and angiogenesis. VEGFR-1 mediated activation of nonmalignant supporting cells, particularly stromal, dendritic, hematopoietic cells, and macrophages, is also likely important for cancer pathogenesis. VEGFR-1 is also hypothesized to enable the development of cancer metastases by means of activation and premetastatic localization in distant organs of bone marrow-derived hematopoietic progenitor cells, which express VEGFR-1. IMC-18F1 is a fully human IgG(1) antibody that binds to VEGFR-1 and has been associated with the inhibition of cancer growth in multiple in vitro and human tumor xenograft models. The preliminary results of phase 1 investigations have also indicated a favorable safety profile for IMC-18F1 at doses that confer antibody concentrations that are associated with relevant antitumor activity in preclinical models.

References

Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·S HiratsukaM Shibuya
Dec 20, 2000·The Journal of Investigative Dermatology·P M LacalS D'Atri
Oct 3, 2003·Current Biology : CB·Richard C BatesArthur M Mercurio
Jan 7, 2004·Nature Reviews. Cancer·Jeffrey W Pollard
Dec 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel J Hicklin, Lee M Ellis
Apr 9, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dong-Goo BaeChi-Bom Chae
Nov 9, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Christian ParrWen G Jiang
May 4, 2006·International Journal of Cancer. Journal International Du Cancer·Yan WuDaniel J Hicklin
May 16, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takashi SetoYukito Ichinose
Nov 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yan WuDaniel J Hicklin
Dec 6, 2006·Cancer Research·Rosandra N KaplanDavid Lyden
May 10, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G GravisP Viens
Aug 7, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Pedro M LacalStefania D'Atri
Oct 17, 2008·The Journal of Biological Chemistry·Salvatore PonticelliSandro De Falco
Nov 26, 2008·Nature Reviews. Cancer·Christian FischerPeter Carmeliet

❮ Previous
Next ❯

Citations

Mar 6, 2013·Nature Reviews. Nephrology·Tetsuhiro Tanaka, Masaomi Nangaku
Jun 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jenny YaoCarlos Bais
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Sina Koch, Lena Claesson-Welsh
May 12, 2011·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Masabumi Shibuya
Sep 6, 2012·International Journal of Molecular Sciences·Magali CastellsBettina Couderc
Jun 1, 2011·Integrative and Comparative Biology·Wendy L Reed, Mark E Clark
Apr 22, 2015·International Journal of Molecular Sciences·Maria Christina TsourlakisStefan Steurer
Mar 7, 2014·Biomolecules & Therapeutics·Masabumi Shibuya
Oct 13, 2015·Biochemistry and Biophysics Reports·Xiaolei WangW Barry Edwards
Jun 30, 2011·The Biochemical Journal·Sina KochLena Claesson-Welsh
Aug 20, 2014·Gastroenterology Research and Practice·Guido GiordanoMassimo Pancione
Dec 11, 2013·Acta Biomaterialia·Harsh D AminNikolaos Donos
Jul 9, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Claudia PeitzschAnna Dubrovska
May 17, 2017·Advanced Drug Delivery Reviews·Ayelet David
May 20, 2011·Nature·Peter Carmeliet, Rakesh K Jain
Oct 14, 2017·The Journal of Pharmacology and Experimental Therapeutics·Maria Grazia AtzoriGrazia Graziani
Feb 28, 2014·The Korean Journal of Internal Medicine·Sandro De Falco
Aug 15, 2019·Cancer Biotherapy & Radiopharmaceuticals·Sara RamezaniShahrokh Yousefzadeh Chabok
Aug 12, 2017·Journal of Experimental & Clinical Cancer Research : CR·Maria Grazia AtzoriGrazia Graziani
Jan 15, 2015·Expert Review of Molecular Diagnostics·Koen M MarienGuido R Y De Meyer
Mar 31, 2017·Molecular and Clinical Oncology·Justyna ZygońRobert Rzepko
Sep 6, 2018·Cell Death & Disease·Aleksei TitovNickolai A Barlev
Nov 9, 2018·International Journal of Molecular Sciences·Toshimitsu YamaokaTohru Ohmori
Feb 6, 2016·International Journal of Oncology·Elena PaganiPedro Miguel Lacal
Nov 3, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jan-Philip MeyerJason S Lewis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.